R&D Changing Faces: Board of Directors and Advisory Boards, Febr... Boardrooms and advisory panels across pharma, biotech, medtech, and digital health were busy last month.
R&D Changing Faces: Board of Directors, January 2026 January was a relatively quiet month for Board news, but there were some notable moves here and there.
R&D Changing Faces: Board appointments, November and December 20... As 2025 came to a close, we also saw a modest number of Board appointments, on both advisory and governance Boards.
R&D Changing Faces – Board of Directors and Advisory Boards - Oc... From high-profile resignations to the addition of seasoned executives and scientific leaders, last month saw a series of notable changes.
R&D Changing Faces – Boards of Directors and Advisory Boards – A... Welcome back to Changing Faces, in our final round-up for August and September there are plenty of Board appointments to report on.
Sales & Marketing Changing Faces – Board of Director and Advisory Board hires ... This month’s boardroom activity across biotech, diagnostics, CROs, and digital health companies highlights a strategic push for scientific excellence, commercial acumen, and global leadersh
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
